Payment overview · 2025
General Payments
$15.65
1 reported records · 1 companies
Healthcare provider profile · identity verified
Brittany Bertsch, DO
Allopathic & Osteopathic Physicians|Family Medicine · WILLISTON, ND · NPI 1457872863
Verified facts
What the public records show
CMS Open Payments records show Brittany Bertsch, DO received $15.65 in general payments during 2025 across 1 reported records.
Medtronic, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$15.65 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $15.65 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MINIMED 780G Normalized: minimed 780g |
Device | Medtronic, Inc. | $15.65 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 271 | 78 |
| Omeprazole | Omeprazole | 174 | 44 |
| Levothyroxine Sodium | Levothyroxine Sodium | 169 | 41 |
| Losartan Potassium | Losartan Potassium | 137 | 40 |
| Amlodipine Besylate | Amlodipine Besylate | 128 | 39 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 120 | 16 |
| Pantoprazole Sodium | Pantoprazole Sodium | 120 | 28 |
| Montelukast Sodium | Montelukast Sodium | 117 | 24 |
| Furosemide | Furosemide | 116 | 27 |
| Lisinopril | Lisinopril | 113 | 31 |
| Metformin Hcl | Metformin Hcl | 107 | 29 |
| Gabapentin | Gabapentin | 106 | 17 |
| Hydrochlorothiazide | Hydrochlorothiazide | 106 | 30 |
| Potassium Chloride | Potassium Chloride | 97 | 21 |
| Metoprolol Succinate | Metoprolol Succinate | 92 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 86 | 17 |
| Celecoxib | Celecoxib | 81 | 16 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 81 | 25 |
| Pregabalin | Pregabalin | 80 | suppressed |
| Eliquis | Apixaban | 78 | 15 |
| Simvastatin | Simvastatin | 75 | 21 |
| Jardiance | Empagliflozin | 69 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 61 | 31 |
| Tramadol Hcl | Tramadol Hcl | 60 | 17 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 58 | 11 |
| Ozempic | Semaglutide | 57 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 52 | 16 |
| Baclofen | Baclofen | 51 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 51 | 14 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 51 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 50 | 14 |
| Famotidine | Famotidine | 49 | 15 |
| Meloxicam | Meloxicam | 48 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 45 | 12 |
| Diclofenac Sodium | Diclofenac Sodium | 44 | 16 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 43 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 41 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 40 | 11 |
| Alprazolam | Alprazolam | 39 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 39 | 13 |
| Synthroid | Levothyroxine Sodium | 39 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 39 | suppressed |
| Carvedilol | Carvedilol | 35 | suppressed |
| Bupropion Xl | Bupropion Hcl | 34 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 32 | suppressed |
| Fentanyl | Fentanyl | 31 | suppressed |
| Savella | Milnacipran Hcl | 31 | suppressed |
| Lorazepam | Lorazepam | 30 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 29 | suppressed |
| Myrbetriq | Mirabegron | 29 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 28 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 26 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 26 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 26 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 26 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 26 | suppressed |
| Tamsulosin Hcl | Tamsulosin Hcl | 25 | suppressed |
| Allopurinol | Allopurinol | 24 | suppressed |
| Chlorthalidone | Chlorthalidone | 24 | suppressed |
| Clonazepam | Clonazepam | 24 | suppressed |
| Xarelto | Rivaroxaban | 24 | suppressed |
| Cefdinir | Cefdinir | 23 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Januvia | Sitagliptin Phosphate | 23 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 23 | suppressed |
| Glipizide Er | Glipizide | 22 | suppressed |
| Spironolactone | Spironolactone | 22 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 22 | suppressed |
| Mounjaro | Tirzepatide | 21 | suppressed |
| Premarin | Estrogens, Conjugated | 21 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 21 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 21 | suppressed |
| Topiramate | Topiramate | 20 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 19 | suppressed |
| Glimepiride | Glimepiride | 19 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Mirtazapine | Mirtazapine | 19 | suppressed |
| Trulicity | Dulaglutide | 19 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 17 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 16 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 16 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 16 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 15 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Methylprednisolone | Methylprednisolone | 15 | 14 |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 11 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 14 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 14 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 14 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 13 | suppressed |
| Aripiprazole | Aripiprazole | 13 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | suppressed |
| Prednisone | Prednisone | 13 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 13 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Estradiol | Estradiol | 12 | suppressed |
| Finasteride | Finasteride | 12 | suppressed |
| Invokana | Canagliflozin | 12 | suppressed |
| Lamotrigine | Lamotrigine | 12 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Prempro | Estrogen,con/M-Progest Acet | 12 | suppressed |
| Roflumilast | Roflumilast | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Topiramate Er | Topiramate | 12 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 11 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 11 | suppressed |
| Ezetimibe | Ezetimibe | 11 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $15.65 · 1 records | Medtronic, Inc. | MINIMED 780G | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error